Betapace Related Published Studies
Well-designed clinical trials related to Betapace (Sotalol)
The efficacy of sotalol in preventing postoperative atrial fibrillation: a
meta-analysis. [2011]
The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker. [2008.08]
Bifocal versus unifocal right atrial pacing under plasma level controlled sotalol to prevent atrial fibrillation in patients with symptomatic sinus bradycardia and paroxysmal atrial fibrillation. [2007.12]
The clinical noncompliance of oral sotalol/magnesium for prophylactic treatment of atrial fibrillation after coronary artery bypass grafting. [2007.07]
Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). [2007.04]
Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial. [2006.09]
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. [2006.07.11]
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. [2006.04]
A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. [2006.04]
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. [2006.01.11]
[Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study] [2006.01.10]
Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia. [2005.09]
Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women. [2005.08]
Amiodarone versus sotalol for atrial fibrillation. [2005.05.05]
The effects of sotalol on ventricular repolarization during exercise. [2005.04]
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. [2004.12.15]
Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. [2004.10]
Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. [2004.06]
Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. [2004.03]
Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. [2004.01]
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). [2003.08.15]
Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium. [2003.06]
Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. [2002.11]
Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. [2002.09]
A randomised cross-over study on the haemodynamic effects of oral dofetilide compared with oral sotalol in patients with ischaemic heart disease and sustained ventricular tachycardia. [2002.06]
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. [2001.12]
Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. [2001.12]
Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. [2001.10]
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. [2001.09.15]
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. [2001.08]
Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study. [2001.01]
Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia. [2000.11]
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? [2000.11]
Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. [2000.09]
The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. [2000.07]
Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. [2000.07]
Well-designed clinical trials possibly related to Betapace (Sotalol)
Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II). [2010.09]
Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization. [2010.07]
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. [2010.03]
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). [2008.09]
Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery. [2008.02]
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. [2008.01]
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. [2007.10]
Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review. [2007.02]
A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. [2006.12.05]
Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial. [2006.11]
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study. [2006.10.01]
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. [2006.08.15]
Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial. [2006.04]
Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. [2005.08]
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction? [2005.06]
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. [2005]
Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study. [2005]
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. [2004.08]
Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. [2004.08]
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. [2004.08]
The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. [2004.07]
A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. [2004.04]
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. [2003.12.16]
Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. [2003.10]
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. [2003.09]
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. [2003.07.02]
Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation. [2003.07]
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results. [2003.06]
Rhythm versus rate control after ablation and pacing for paroxysmal atrial fibrillation: clinical implications of the PAF 2 trial. [2003.06]
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. [2003.05.21]
Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. [2003.04]
Intracardiac low-energy versus transthoracic high-energy direct-current cardioversion of atrial fibrillation: a randomised comparison. [2003]
[Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation] [2002.12]
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries. [2002.10]
Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. [2002.08.15]
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. [2002.07]
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. [2002.06]
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. [2002.06]
Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence. [2001.09]
Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. [2001.08.15]
Shortening the second phase duration of biphasic shocks: effects of class III antiarrhythmic drugs on defibrillation efficacy in humans. [2001.07]
Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. [2001.01]
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. [2000.12]
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. [2000.10.01]
Other research related to Betapace (Sotalol)
One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis. [2011.11]
The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis. [2011.09]
Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement. [2011.08]
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. [2011.03]
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and
propafenone, for the management of atrial fibrillation. [2011]
Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study. [2010.08]
Developing a safe intravenous sotalol dosing regimen. [2010.07]
Massive ingestion of cardiac drugs: toxicokinetic aspects of digoxin and sotalol during hemofiltration. [2010.03]
Sotalol and a broken heart. [2010.02]
The time course of new T-wave ECG descriptors following single- and double-dose administration of sotalol in healthy subjects. [2010.01]
QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. [2010]
Developing a safe intravenous sotalol dosing regimen. [2010]
Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes. [2009.12]
d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing. [2009.10]
Intrapericardial delivery of amiodarone and sotalol: atrial transmural drug distribution and electrophysiological effects. [2009.10]
[Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation] [2009.09.06]
Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature. [2009.09]
Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol. [2009.08.21]
Intrapericardial Delivery of Amiodarone and Sotalol: Atrial Transmural Drug Distribution and Electrophysiological Effects. [2009.08.20]
Sotalol as adjunctive therapy to implantable cardioverter-defibrillators in heart failure patients. [2009.05]
Evaluation of drug-induced QT prolongation in a halothane-anesthetized monkey model: effects of sotalol. [2009.03]
|
